New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study says Drug manufacturer Eli Lilly releases promising new data about its weight loss pill in clinica ...

SINGAPORE] Logistics company GLP said on Tuesday it had secured an investment of 2.5 billion yuan (S$449 million) from ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s | ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...

In 2024, 26.5% of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables.

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...